You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Recro Gainesville LLC v. Actavis Laboratories FL, Inc. (D. Del. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Recro Gainesville LLC v. Actavis Laboratories FL, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for Recro Gainesville LLC v. Actavis Laboratories FL, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2017-10-30 1 PageID #: 5 Patent Nos. 6,228,398 (the “’398 Patent); 6,902,742 (the “’742 Patent”); and 9,132,096…United States Patent No. 9,713,611 (“the ’611 Patent”). This action is based upon the Patent Laws of the…’611 Patent is a continuation of the ’096 Patent. The ’611 and ’096 Patents expire on the same day. …constitutes infringement of the ’398 Patent; the ’742 Patent; and the ’096 Patent. Those actions, filed on September…infringement of the grandparent patent of the presently asserted ’611 Patent. Recro I and this case are External link to document
2017-10-30 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,713,611 B2. (fms) (Entered:…2017 29 January 2018 1:17-cv-01535 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.